Circulating OPG levels are reduced following infliximab treatment and correlate with CRP levels: Is serum OPG a potential marker of IBD disease activity?

Authors

  • Emanuela Galliera PhD,

    1. Department of Human Morphology and Biomedical Sciences, “Città Studi”, Laboratory of Clinical Pathology, University of Milan, Milan, Italy
    Search for more papers by this author
  • Laura de Girolamo PhD,

    1. Orthopaedic Biotechnology Laboratory, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy
    Search for more papers by this author
  • Giada Dogliotti PhD,

    1. Department of Human Morphology and Biomedical Sciences, “Città Studi”, Laboratory of Clinical Pathology, University of Milan, Milan, Italy
    Search for more papers by this author
  • Carlo De Salvo PhD,

    1. Gastroenterology and Gastrointestinal Endoscopy Unit, IRCCS Policlinico San Donato, San Donato Milanese, Italy
    2. Department of Pathology, Case Western Reserve University, Cleveland, Ohio
    Search for more papers by this author
  • Giulia Tosetti MD,

    1. Gastroenterology and Gastrointestinal Endoscopy Unit, IRCCS Policlinico San Donato, San Donato Milanese, Italy
    Search for more papers by this author
  • Luca Pastorelli MD

    1. Gastroenterology and Gastrointestinal Endoscopy Unit, IRCCS Policlinico San Donato, San Donato Milanese, Italy
    2. Department of Medical and Surgical Sciences, University of Milan, Milan, Italy
    Search for more papers by this author

  • The authors thank Maurizio Vecchi and Massimiliano Marco Corsi for continued support and mentorship. This work was supported by the Italian Ministry of University and Research PRIN grant 2007K4HZEJ_004 (to M.V.). The authors have no conflicting financial interests.

No abstract is available for this article.

Ancillary